The Pharma Partnership Models Reshaping How New Drugs Reach Patients
The pharmaceutical industry relies on partnership models for drug development and manufacturing, predominantly involving Contract Development and Manufacturing Organizations (CDMOs) over Contract Manufacturing Organizations (CMOs). This shift reflects the increasing complexity of drugs and the need for specialized expertise, impacting speed to market, supply reliability, and medicine quality for patients.

